News

A U.K. health agency said the Alzheimer's drugs Kisunla and Leqembi are not cost-effective, meaning they won't be offered through the NHS.
M onths after Labour won a landslide election in 1945, the party’s new health secretary predicted that its National Health Service (NHS) would be the “envy” of the world. In ...
The Food and Drug Administration announced the launch of a new program to fast-track agency approvals for drug manufacturers ...